- CAREER FEATURE
- Correction 27 August 2024
Whistleblowing in science: this physician faced ostracization after standing up to pharma
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-024-02743-5
This interview has been edited for length and clarity.
Updates & Corrections
-
Correction 27 August 2024: An earlier version of this story erroneously indicated that Nancy Olivieri questioned the legality of using unlicensed drugs in clinical trials.
References
Olivieri, N. F. et al. N. Engl. J. Med. 339, 417–423 (1998).
Olivieri, N. F., Sabouhanian, A. & Gallie, B. L. PLoS ONE 14, e0211942 (2019).